Back to companies

Turning Point Therapeutics Inc: Premium Databases

Turning Point Therapeutics Inc Clinical Trials

Determine Turning Point Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

A sample of Turning Point Therapeutics Inc Clinical Trials data

Trial Title Trial Identifier Drug Name Therapy Area Indication Trial Phase Trial Status Sponsor
Showing 3 of 8 results. Subscribe to unlock more.
Deserunt mollit sunt Lorem GDCTXXXX Lorem Lorem Lorem XXXX Planned Pfizer Inc
Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients (TOTEM) GDCT0414147 repotrectinib Oncology Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis); Non-Small Cell Lung Cancer; Solid Tumor Phase I Ongoing, recruiting Dr Rosell Oncology Institute
A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors GDCT0405849 repotrectinib Oncology Non-Small Cell Lung Cancer; Solid Tumor Phase I/II Ongoing, recruiting Turning Point Therapeutics Inc
A Phase Ib/II Study of TPX-0022 in Combination with Aumolertinib in EGFR Mutant MET-Amplified Advanced Non-Small Cell Lung Cancer GDCT0405830 aumolertinib mesylate; TPX-0022 Oncology Non-Small Cell Lung Cancer Phase I/II Planned Turning Point Therapeutics Inc
Clinical Trials


GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.

The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.

Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:

  • 250+ clinical trial registries
  • 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.


The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).


  • Detailed trial information.
  • Drug information.
  • Patient information, including inclusion and exclusion criteria.
  • Trial results, as reported in the public domain.
  • Biomarkers used for patient stratification/selection & outcome measures.
  • Enrolment parameters.
  • Investigators involved in clinical trials.
  • Trials sites and locations.
  • Contact information.


Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.

Geographic Analysis - see where trials are being run.

Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.

Find information on trials contacts, as well as Site and Investigator information.

Get information on trial successes and failures.

Get intelligence on CROs engaged in clinical trials.

Use as a business development tool for CROs.

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.


Access more premium companies when you subscribe to Explorer